FINWIRES · TerminalLIVE
FINWIRES

Sino Biopharma Unit to Commercialize GSK Respiratory Drugs in Mainland China

By

Sino Biopharmaceutical (HKG:1177) said subsidiary Chia Tai Tianqing Pharmaceutical expanded its collaboration with GlaxoSmithKline to commercialize two respiratory products in mainland China.

Chia Tai Tianqing will obtain commercialization rights for GSK's Trelegy Ellipta and Anoro Ellipta in mainland China and will handle importation, distribution, hospital access and promotional activities for the products, according to a Hong Kong bourse filing on Wednesday.

The products are combination inhalation therapies used in the treatment of respiratory conditions.

Related Articles

Asia

Arealink's Hello Storage Utilization Rate Down to 79% in June

Arealink (TYO:8914) said the utilization rate at its Hello Storage facilities slipped to 78.82% at the end of June, down from 83.16% a year earlier, as newly opened sites continued to ramp up, according to a Monday filing with the Tokyo Stock Exchange.Existing-facility utilization stood at 86.62%, compared with 89.74% in June 2025, while new facilities recorded a 47.98% usage rate, down from 49.89% a year earlier. Total units reached 134,612, with 106,096 in use.The company opened 28 new facilities in June, including locations in Tokyo, Kyoto, Chiba, Saitama, Aichi, Kyoto and Fukuoka. Partner-facility additions included two units. Four facilities were closed.

TYO:8914
Asia

Magellanic Cloud Unit Wins INR63 Million South Central Railway Contract

Magellanic Cloud (NSE:MCLOUD, BOM:538891) said its wholly owned subsidiary, Provigil Surveillance, has received a letter of acceptance from South Central Railway's Vijayawada Division for a contract worth about 62.5 million Indian rupees.The nine-month project covers the installation and upgrade of video surveillance systems at multiple railway stations, including facilities for the Godavari Pushkaram 2027 event, as well as deployment of video recording systems in relay and station master rooms across the Vijayawada Division, according to a Monday Indian stock exchange filing.Shares of the surveillance technology firm fell nearly 1% in recent trade.

BOM:538891NSE:MCLOUD
Asia

Jiangsu Etern Forecasts Up to 120% Jump in H1 Profit; Shares Fall 8%

Jiangsu Etern (SHA:600105) forecasts first-half attributable net profit of between 500 million yuan and 700 million yuan, compared with 318.5 million yuan the previous year.The between 57% and 120% year-over-year increase is driven by the optical communications segment, which benefited from the digital economy acceleration and booming artificial intelligence computing demand, according to a Monday filing with the Shanghai bourse.Shares of the telecommunication cable and wire manufacturer fell 8% in recent trade.

SHA:600105